Videos

Colleen Kelley, MD, MPH, describes what's on the horizon in HIV prevention.

Ian Frank, MD, explains the "Ending the Epidemic" initiative.

Colleen Kelley, MD, MPH, describes the current state of HIV vaccine efforts.

Colleen Kelley, MD, MPH, discusses the importance of targeted youth HIV prevention measures.

Colleen Kelley, MD, MPH, associate professor at the Emory University School of Medicine, discusses some of the ongoing themes in developing HIV science.

Ian Frank, MD, discusses the need to include women in HIV research.

Colleen Kelley, MD, MPH, describes barriers to the implementation of HIV pre-exposure prophylaxis.

Ian Frank, MD, discusses the global character of the novel coronavirus.

Jason Gallagher, PharmD, discusses the risk factors for experiencing complications of influenza.

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, discusses the significant drug approvals in ID over the course of 2019.

Jason Tokumoto, MD, reflects on the ways people respond to HIV diagnosis.

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, explains some of the factors which underlie the cost of ID treatment.

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, explains contemporary challenges facing ID clinicians individually and as a profession.

Mark Riddle, MD, DrPH, speaks to Contagion at ACG 2019 about the results of a study looking into microbiome changes associated with single-dose antibiotics for the treatment of traveler's diarrhea.

Jason Tokumoto, MD, explains the need to look beyond nonadherence and understand a patient with HIV as a complex person.

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, discusses areas of unmet need and challenges ahead in the ID development economic landscape.

Jason Tokumoto, MD, discusses the evolution of HIV treatment.

Andrea L. Cox, MD, PhD, comments on the future of HCV vaccine development efforts in light of the 2019 trial which did not prevent chronic infection.

Mark Riddle, MD, DrPH, speaks to Contagion about preventing drug resistance in people who acquire traveler's diarrhea.

Andrea L. Cox, MD, PhD, discusses the implications of discovering that an experimental vaccine was not effective at preventing chronic hepatitis C virus.

Daniel Chastain, PharmD, BCIDP, discusses how antiretroviral stewardship might practically be implemented in the context that antimicrobial stewardship as a whole is often underdeveloped.

Andrea L. Cox, MD, PhD, discusses some of the challenges in developing a vaccine for hepatitis C and details the results of a vaccine trial.

Max Brito, MD, MPH, explains the value of bringing safe, confidential, and non-stigmatizing HIV treatment to the community at IDWeek2019.

Daniel B. Chastain, PharmD, BCIDP, AAHIVP, clinical assistant professor at the University of Georgia College of Pharmacy, explains antiretroviral stewardship.

Andrea L. Cox, MD, PhD, compares the rates of hepatitis C and hepatitis B diagnoses since the start of the opioid epidemic.

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, explains why everyone needs a flu shot and addresses skepticism toward the vaccine.

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, discusses changes in public health and society since the early 20th century in response to speculation about whether large-scale global pandemics are still possible in the 21st century.

Pamela Gorman, RN, ACRN, describes the benefits of connecting care to incarcerated people with HIV.